4//SEC Filing
Kemps-Polanco Reshema 4
Accession 0001127602-25-015483
CIK 0001100682other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:17 PM ET
Size
8.8 KB
Accession
0001127602-25-015483
Insider Transaction Report
Form 4
Kemps-Polanco Reshema
Director
Transactions
- Award
Common Stock
2025-05-21$134.98/sh+630$85,037→ 2,590 total - Award
Common Stock
2025-05-21$134.98/sh+946$127,691→ 1,960 total - Award
Stock Options (Right to Buy)
2025-05-21$134.98/sh+2,076$280,218→ 2,076 totalExercise: $134.98From: 2026-05-21Exp: 2035-05-21→ Common Stock (2,076 underlying)
Footnotes (3)
- [F1]The unvested restricted stock units vest upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders.
- [F2]The grant was made in lieu of director service fees for the term commencing May 20, 2025. The restricted stock units vest upon the earlier of 5/21/2026, or the business day prior to the Company's next annual meeting of shareholders.
- [F3]The stock options become exercisable upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders.
Documents
Issuer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CIK 0001100682
Entity typeother
Related Parties
1- filerCIK 0002009357
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:17 PM ET
- Size
- 8.8 KB